Background There is a growing literature showing that critically ill COVID-19 patients have
an increased risk of pulmonary co-infections and superinfections. However, studies in …

There are few publications on the impact of coinfection and superinfection in patients with
COVID-19. Patients with higher severity are much more prone to secondary bacterial, fungal …

Background At outset of the coronavirus disease 2019 (COVID-19) pandemic, the
significance of bacterial and fungal coinfections in individuals with COVID-19 was unknown …

To the Editors: Bacterial coinfections are common complications of viral respiratory
infections. In patients with influenza, bacterial coinfections range from 2% to 65%. 1 In …

While it is reported that COVID-19 patients are more prone to secondary bacterial infections,
which are strongly linked to the severity of complications of the disease, bacterial …

In people with viral respiratory tract infections, the presence of a concomitant bacterial
infection has been associated with poor clinical outcomes. For example, in patients with …

Purpose Thorough knowledge of the nature and frequency of co-infections is essential to
optimize treatment strategies and risk assessment in cases of coronavirus disease 2019 …

Background Co‐infections, secondary bacterial or fungal infections, are important risk
factors for poor outcomes in viral infections. The prevalence of co‐infection and secondary …

Purpose The impact of respiratory coinfections in COVID-19 is still not well understood. This
study sought to identify the respiratory pathogens causing coinfections in patients with …

Abstract Background SARS-CoV-2, a novel corona virus, has caused clusters of fatal
pneumonia worldwide. Immune compromised patients are among the high risk groups with …